explore -WSS

explore

author：knowledge 2025-08-12 05:32:37 - browse：9

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

focus

WSS

North Korean leader's powerful sister says warplanes repelled US spy plane

Another man arrested in connection with shooting at Kansas nightclub

Activists slam private health insurers over coverage restrictions

Kansas must stop changing trans people's sex listing on driver's licenses, judge says

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

focus

explore

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

Another man arrested in connection with shooting at Kansas nightclub

As demand for Covid shots wanes, Moderna seeks its next success

Supreme Court strikes down use of affirmative action

BioMarin wins approval for gene therapy to treat hemophilia A

Medical records are filled with copy

Bright Health sells Medicare Advantage business to Molina

How corporate America is slashing DEI workers amid backlash to diversity programs

Hepatitis C has a cure — but many Americans still lack access to it

Malaria cases in Florida and Texas: Here’s what you need to know

knowledge

With fresh data, a dynamic duo powers Eli Lilly to new heights

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

With fresh data, a dynamic duo powers Eli Lilly to new heights

How to save PrEP access — and even expand it

The PBM ad wars are taking over Washington, D.C.

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Wikipedia

focus

knowledge

hotspot